Copeptin: a neuroendocrine biomarker of COVID-19 severity

Aim: To investigate the change in a serum level of copeptin, a neuroendocrine biomarker, in differentiating grades of COVID-19 severity on admission time and to find its diagnostic potential. Materials & Methods: 160 COVID-19 patients were classified according to disease severity into 80 mild to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammad, Reham, Elshafei, Ahmed, Khidr, Emad Gamil, El-Husseiny, Ahmed A, Gomaa, Maher H, Kotb, Hend G, Eltrawy, Heba H, Farhoud, Hesham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966690/
https://www.ncbi.nlm.nih.gov/pubmed/35350852
http://dx.doi.org/10.2217/bmm-2021-1100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966690/
https://www.ncbi.nlm.nih.gov/pubmed/35350852
http://dx.doi.org/10.2217/bmm-2021-1100

Ejemplares similares